Initial antiretroviral therapy: The dilemmas ahead

被引：0
|
作者：
Arribas, Jose R. [1 ]
机构：
[1] Hosp Univ La Paz, Internal Med Serv, HIV Unit, IdiPAZ, Madrid, Spain
来源：
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2013年 / 31卷 / 02期
关键词：
CO-FORMULATED ELVITEGRAVIR; NON-INFERIORITY TRIAL; NAIVE ADULTS; DOUBLE-BLIND; HIV-1; INFECTION; TENOFOVIR; PHASE-3; EMTRICITABINE; EFAVIRENZ; RILPIVIRINE;
D O I：
10.1016/j.eimc.2012.07.011
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：68 / 70
页数：3
相关论文
共 50 条
  • [21] Adult antiretroviral therapy guidelines 2017
    Meintjes, Graeme
    Moorhouse, Michelle A.
    Carmona, Sergio
    Davies, Natasha
    Dlamini, Sipho
    Van Vuuren, Cloete
    Manzini, Thandekile
    Mathe, Moeketsi
    Moosa, Yunus
    Nash, Jennifer
    Nel, Jeremy
    Pakade, Yoliswa
    Woods, Joana
    Van Zyl, Gert
    Conradie, Francesca
    Venter, Francois
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2017, 18 (01)
  • [22] Prescribing for patients taking antiretroviral therapy
    Hughes, Yasmin
    Tomlins, Louise
    Usherwood, Tim
    AUSTRALIAN PRESCRIBER, 2022, 45 (03) : 80 - 87
  • [23] Adipocytes impair efficacy of antiretroviral therapy
    Couturier, Jacob
    Winchester, Lee C.
    Suliburk, James W.
    Wilkerson, Gregory K.
    Podany, Anthony T.
    Agarwal, Neeti
    Chua, Corrine Ying Xuan
    Nehete, Pramod N.
    Nehete, Bharti P.
    Grattoni, Alessandro
    Sastry, K. Jagannadha
    Fletcher, Courtney, V
    Lake, Jordan E.
    Balasubramanyam, Ashok
    Lewis, Dorothy E.
    ANTIVIRAL RESEARCH, 2018, 154 : 140 - 148
  • [24] Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz
    Lucas, GM
    Chaisson, RE
    Moore, RD
    AIDS, 2001, 15 (13) : 1679 - 1686
  • [25] Associations of modern initial antiretroviral therapy regimens with all-cause mortality in people living with HIV in resource-limited settings: a retrospective multicenter cohort study in China
    Wu, Xinsheng
    Wu, Guohui
    Ma, Ping
    Wang, Rugang
    Li, Linghua
    Chen, Yuanyi
    Xu, Junjie
    Li, Yuwei
    Li, Quanmin
    Yang, Yuecheng
    Wang, Lijing
    Xin, Xiaoli
    Qiao, Ying
    Fu, Gengfeng
    Huang, Xiaojie
    Su, Bin
    Zhang, Tong
    Wang, Hui
    Zou, Huachun
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [26] Update and latest advances in antiretroviral therapy
    Menendez-Arias, Luis
    Delgado, Rafael
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (01) : 16 - 29
  • [27] Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy
    Leporrier, Jeremie
    Etienne, Manuel
    Chapuzet, Claire
    Peytavin, Gilles
    Bord, Stephane
    Borsa-Lebas, Francoise
    Caron, Francois
    Plantier, Jean-Christophe
    Mourez, Thomas
    JOURNAL OF CLINICAL VIROLOGY, 2014, 60 (04) : 428 - 430
  • [28] Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy
    Viswanathan, Shilpa
    Justice, Amy C.
    Alexander, G. Caleb
    Brown, Todd T.
    Gandhi, Neel R.
    McNicholl, Ian R.
    Rimland, David
    Rodriguez-Barradas, Maria C.
    Jacobson, Lisa P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (04) : 493 - 498
  • [29] Integrase inhibitors: current protagonists in antiretroviral therapy
    Loaiza, John D.
    Chvatal-Medina, Mateo
    Hernandez, Juan C.
    Rugeles, Maria T.
    IMMUNOTHERAPY, 2023, : 1477 - 1495
  • [30] Current status and challenges of antiretroviral research and therapy
    Este, Jose A.
    Cihlar, Tomas
    ANTIVIRAL RESEARCH, 2010, 85 (01) : 25 - 33
12345